OSCR

Oscar Health (OSCR) is positioned as the stronger investment compared to Molina Healthcare (MOH), driven by robust 46% membership growth, 70% revenue increase, a 20% revenue CAGR target through 2027, and a lower valuation multiple. Molina faces headwinds from rising medical costs, enrollment challenges, and portfolio restructuring, with a projected 2027 exit from its MAPD business and $1 billion marketplace premium reduction.

ASX Limited - Unsponsored ADR (ASXFY) is significantly outperforming the Finance sector year-to-date, returning 26.3% compared to the sector average of 3.3%. The stock holds a Zacks Rank #1 (Strong Buy) with analyst sentiment improving, as consensus earnings estimates have risen 9.9% in the past quarter. Oscar Health, Inc. (OSCR) is another standout performer in the Finance sector with 132.9% year-to-date returns and a Zacks Rank #1 rating.

Despite recent market volatility driven by AI concerns, rising rates, and geopolitical tensions, three stocks with strong Zacks Rank #1 ratings stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and Heico demonstrates consistent aerospace and defense sector strength. All three show improving earnings estimates and constructive technical setups independent of AI boom dependency.